• Return to Headlines

Uptrend Call Working As Genmark Diagnost Stock Rises 50.0% (GNMK)

By Shiri Gupta

SmarTrend identified an Uptrend for Genmark Diagnost (NASDAQ:GNMK) on January 9th, 2018 at $5.42. In approximately 8 months, Genmark Diagnost has returned 49.95% as of today's recent price of $8.12.

In the past 52 weeks, Genmark Diagnost share prices have been bracketed by a low of $3.63 and a high of $9.96 and are now at $8.12, 124% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 1.4%.

GenMark Diagnostics Inc. is a molecular diagnostics company focused on developing and commercializing its biomarker detection technology. The Company's system supports a broad range of molecular diagnostic tests with a compact workstation and self-contained disposable test cartridges.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Genmark Diagnost shares.

Log in and add Genmark Diagnost (GNMK) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights genmark diagnost

Ticker(s): GNMK